Article
Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer
29 Sept 2022
Abstract excerpt
Early cancer detection by cell-free DNA faces multiple challenges: low fraction of tumor cell-free DNA, molecular heterogeneity of cancer, and sample sizes that are not sufficient to reflect diverse patient populations. Here, we develop a cancer detection approach to address these challenges. It consists of an assay, cfMethyl-Seq, for cost-effective sequencing of the cell-free DNA methylome (with > 12-fold...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
